Low Incidence of Post-Transplant EBV-Related Disease After Alemtuzumab-Mediated T Cell Depletion Is Explained by the Differential Susceptibility to Alemtuzumab of B Cells and Protective CD8 and CD4 T Cells

Author(s):
Halkes, C.J.M.; Jedema, I.; Wolbers, J.O.; Egmond, E.M. van; Borne, P.A. von dem; Marijt, E.W.A.F.; Falkenburg, J.H.F.
Published
2010
Publication type
Other
Date issued
2010-11-19
Language
English
hdl
1887/118269